Medistim ASA (LON:0OCD)
229.00
+9.00 (4.09%)
At close: Jul 3, 2025
Medistim ASA Revenue
Medistim ASA had revenue of 181.55M NOK in the quarter ending March 31, 2025, with 35.70% growth. This brings the company's revenue in the last twelve months to 603.92M, up 14.89% year-over-year. In the year 2024, Medistim ASA had annual revenue of 556.16M with 6.73% growth.
Revenue (ttm)
603.92M NOK
Revenue Growth
+14.89%
P/S Ratio
6.62
Revenue / Employee
3.92M NOK
Employees
154
Market Cap
294.14M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 556.16M | 35.05M | 6.73% |
Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Indivior | 905.57M |
Medistim ASA News
- 4 months ago - Medistim ASA (STU:MD1) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Innovations ... - GuruFocus
- 4 months ago - Q4 2024 Medistim ASA Earnings Call Transcript - GuruFocus